Excitement Over CAR-Engineered T-cells in Leukemia and Lymphoma Medscape This was a patient who had undergone 10 prior therapies, including many different combinations of rituximab plus chemotherapy regimens, and the disease progressed a month after chemotherapy finished, so she was "clearly refractory," he said. "Our data ... Treated T-cells induce remissions in chemo-refractory B-cell lymphomas |
